Latest news, press releases, and SEC filings for CRISPR Therapeutics AG (CRSP) https://caymanjournal.com/stock/CRSP en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Tue, 28 Apr 2026 02:09:48 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 *⚠️ Since no actual text content or filing data was provided in the document block, this summary is based on the mandatory structure and required content for an **Annual Proxy Statement (ARS)** filing for CRISPR Therapeutics AG (CRSP). It explains what information readers should look for and how to https://caymanjournal.com/stock/CRSP/sec-filing/0001193125-26-165183 https://caymanjournal.com/stock/CRSP/sec-filing/0001193125-26-165183 Tue, 21 Apr 2026 00:00:00 GMT SEC Filing # 📜 What This Document Is 🗳️ This is a **Definitive Proxy Statement (DEF 14A)**. Think of it as an official instruction manual that CRISPR Therapeutics AG (CRSP) is providing to its shareholders before an Annual General Meeting (AGM). 🧐 The purpose is to inform you about the matters the company https://caymanjournal.com/stock/CRSP/sec-filing/0001193125-26-165158 https://caymanjournal.com/stock/CRSP/sec-filing/0001193125-26-165158 Tue, 21 Apr 2026 00:00:00 GMT SEC Filing